Sopan Pharmaceuticals Limited Appoints Rajiv Kumar Sharma As New Chief Executive Officer
30th July 2026, Kathmandu
Sopan Pharmaceuticals Limited has officially appointed Rajiv Kumar Sharma as its new Chief Executive Officer (CEO).
Sopan Pharmaceuticals New CEO Appointed
The executive appointment was finalized during a Board of Directors meeting held at 6:00 PM on Shrawan 13, 2083.
During the meeting, board members unanimously approved Sharma’s leadership role within the pharmaceutical company.
Executive Responsibilities And Strategic Growth
In his new role as Chief Executive Officer, Sharma will oversee executive management and guide strategic and operational activities.
Advertisement
The company anticipates that his leadership will drive organizational growth, streamline manufacturing operations, and strengthen executive management.
- Strategic Direction: Guiding corporate planning, product portfolio expansion, and market positioning across Nepal.
- Operational Oversight: Managing daily business functions, regulatory compliance, and quality control standards.
- Leadership Development: Strengthening corporate management structures to support long-term business goals.
Strategic Details and Corporate Timeline
Sopan Pharmaceuticals has not disclosed specific details regarding the effective start date or exact tenure duration of the appointment.
No immediate operational shifts or new strategic initiatives were announced immediately following the leadership transition.
The appointment reflects the company’s focus on maintaining strong corporate governance and leadership stability within Nepal’s domestic pharmaceutical sector.
For More: Sopan Pharmaceuticals New CEO Appointed
